Application
SLC2A1 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SLC2A1 antibody detected the SLC2A1 protein (arrow).| Product Name | SLC2A1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SLC2A1; GLUT1; Solute carrier family 2, facilitated glucose transporter member 1; Glucose transporter type 1, erythrocyte/brain; HepG2 glucose transporter |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | GLUT1 |
|---|---|
| Alternative Names | SLC2A1 GLUT1 Solute carrier family 2 facilitated glucose transporter member 1 Glucose transporter type 1 erythrocyte/brain HepG2 glucose transporter |
| Molecular Weight(MW) | 54084 Da |
| Function | Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses |
| Tissue Specificity | Expressed at variable levels in many human tissues |
| Cellular Localization | Cell membrane; Multi-pass membrane protein (By similarity). Melanosome. Note=Localizes primarily at the cell surface (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV |
| Entrez Gene | 6513 |
|---|---|
| Nucleotide Accession | NP_006507.2 |
Application
SLC2A1 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SLC2A1 antibody detected the SLC2A1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
